(Q47759700)

5 February 2018

title

Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery--who fails in the early postoperative course? (English)

1 reference

5 February 2018

0 references

C Jurowich

1

1 reference

5 February 2018

A Thalheimer

2

1 reference

5 February 2018

D Hartmann

3

1 reference

5 February 2018

G Bender

4

1 reference

5 February 2018

F Seyfried

5

1 reference

5 February 2018

C T Germer

6

1 reference

5 February 2018

C Wichelmann

7

1 reference

5 February 2018

publication date

1 October 2012

1 reference

5 February 2018

published in

Obesity Surgery

1 reference

5 February 2018

volume

22

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

page(s)

1521-1526

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s11695-012-0676-2

exact match

0 references

cites work

Potential of surgery for curing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Bariatric surgery: an IDF statement for obese Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Outcomes of bariatric surgery in patients with body mass index <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Surgical treatment of type 2 diabetes: the surgeon perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0676-2

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22588846

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")--pilot study of a new operation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22588846

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11695-012-0676-2

1 reference

5 February 2018

1 reference

5 February 2018